Podcasts about Drug treatment

This episode covers: Cardiology This Week: A concise summary of recent studies ICD Indications in primary prevention Drug treatment of cardiac amyloidosis Mythbusters Host: Rick Grobbee Guests: Carlos Aguiar, Gerhard Hindricks, Marianna Fontana Want to watch that episode? Go to: https://esc365.escardio.org/event/1810   Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors.  This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English-language always prevails. Declarations of interests: Stephan Achenbach, Rick Grobbee, Gerhard Hindricks and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Marianna Fontana has declared to have potential conflicts of interest to report: consultancy for Alnylam, Alexion/Caelum Biosciences, Astrazeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Prothena, Pfizer, Novonordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astrazeneca, Pfizer. Share options in LexeoTherapeutics and shares in Mycardium. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Brian O'Connell, RTÉ reporter

Transcript: Transcripts/JudgeBurns.pdf

Over 13 thousand people sought help for problem drug use last year. New figures from the Health Research Board show it's the highest annual number recorded to date, and an increase of 191 cases compared to 2023. Cocaine is the most common drug, accounting for 40 percent of all drug treatment cases - this is a 7 per cent increase on the figure for 2023. Sara Cassidy, Head of Clinical Services at Aiseirí says there's an increasing trend of cocaine use amongst people in rural areas... To discuss this further, Alan Morrissey was joined by Polydrug/Cocaine Initiative Co-Ordinator at Bushypark Addiction Treatment Centre, Maurice Crowe. Photo(C): pixelshot via canva

Dr Suzi Lyons, Senior Researcher at the HRB, chats to JP about the figures from the HRB's Drug treatment demand in Ireland 2024 Hosted on Acast. See acast.com/privacy for more information.

The head of Kentucky's Office of Drug Control Policy talks about the progress being made to curb overdose deaths, Kentucky's top cop is taking a new approach on drug prevention, Congressman Barr announces he's running for U.S. Senate, and state lawmakers ask the federal government to delay the implementation of the REAL ID Act.

Alberta is one step closer to a new law allowing forced treatments for addiction, even if the patient says "no". We ask if you think it will hurt or help those suffering from addiction.

Renal Denervation: Newest Non-Drug Treatment for Hypertension.In this Hypertension Resistant to Treatment episode, we hear from Dr. Dheeraj Rajan, Interventional Radiology Specialist from Canada, talks about how renal denervation came about, and he gives a description of the procedure. Tune in for information on the right patient for this procedure and what primary care providers, specialists, and care teams should know before making a referral.Join us as we explore:Patient selection criteria – What makes someone an ideal candidate for renal denervation?Interviews with interventional specialists – Hear from providers who perform renal denervation and how they assess patients.Perspectives from treating providers – Learn how post-procedure care and monitoring are managed in real-world practice.Patient stories – Real experiences from individuals who have undergone the procedure: what changed, what didn't, and what they wish they knew beforehand.Whether you're a primary care provider, cardiologist, nephrologist, or just curious about the evolving treatment landscape for hypertension, these episodes are packed with insights, clinical pearls, and practical takeaways.

Utah law enforcers announce lives saved milestone with opioid reversal drug -- Rep. Tyler Clancy hosts forum on drug treatment policy bills

Treatment for Low Bone Density: Osteoboost.

Should we force people into treatment for drug addiction, even if it's against their will? On the show, we hear two first person accounts from both sides of the forced treatment conversation.

Alberta plans to build two involuntary drug addiction treatment centres, for people who won't or can't seek treatment themselves. Matt Galloway asks Alberta's Minister of Mental Health and Addiction Dan Williams why his government believes this is the right approach — and what evidence there is to show that forced treatment helps.

Drs Carol H. Wysham and Scott Isaacs discuss incorporating the screening and management of metabolic dysfunction–associated steatotic liver disease in endocrine practice. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002045. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Type 2 Diabetes Mellitus https://emedicine.medscape.com/article/117853-overview Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review https://pubmed.ncbi.nlm.nih.gov/37700494/ Fibrosis-4 (FIB-4) Calculator https://www.hepatitisc.uw.edu/page/clinical-calculators/fib-4 Liver Fibrosis Assessment: MR and US Elastography https://pubmed.ncbi.nlm.nih.gov/34687329/ Using the FIB-4, Automatically Calculated, Followed by the ELF Test in Second Line to Screen Primary Care Patients for Liver Disease https://pubmed.ncbi.nlm.nih.gov/38806580/ American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD) https://pubmed.ncbi.nlm.nih.gov/35569886/ Mediterranean Diet and Nonalcoholic Fatty Liver Disease https://pubmed.ncbi.nlm.nih.gov/29785077/ Drug Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress and Direction https://pubmed.ncbi.nlm.nih.gov/39470028/ Current Status of Glucagon-Like Peptide-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Clinical Perspective https://pubmed.ncbi.nlm.nih.gov/39801787/ Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK576405/ Update on the Applications and Limitations of Alpha-Fetoprotein for Hepatocellular Carcinoma https://pubmed.ncbi.nlm.nih.gov/35110946/

As in, actual views, not weird stories about dead things.

Send us a message with this link, we would love to hear from you. Standard message rates may apply.This week, we're discussing a significant development in the treatment of obstructive sleep apnea (OSA). The FDA has recently approved Zepbound, a medication used in combination with diet and exercise, as the first drug option for moderate to severe OSA in adults with obesity. We'll break down how Zepbound works by targeting hormones that reduce appetite, which leads to weight loss, and how this can improve OSA symptoms. We'll also explore the details of the clinical trials that led to this approval, including how they measured the medication's effectiveness and what potential side effects patients should be aware of.Support the showProduction and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

Hardin County Attorney Jenny Oldham discussed options that her office offers to help people get help for their loved ones who are using drugs.

In Washington state, a law known as Ricky's Law, allows authorities to force people with addiction into treatment. The law is named after Ricky Garcia, whose struggles with drugs and alcohol inspired him and his friend Lauren Davis to push for change.From emergency room visits to suicide attempts, Davis watched as Garcia went through more than 75 emergency visits in just two years. Davis helped spearhead the state's involuntary treatment law and later went on to become a state lawmaker.But does forcing someone into treatment actually work?CBC journalist Julia Wong went to Washington state to find out how the law has been working in practice. In her documentary, Ricky's Law, she speaks to doctors and pa tients who've been through this system. It's a timely conversation as provinces in Canada are considering similar laws.Plus, a look at how New Brunswick ended up making a two-seater sports car in the 1970s called the Bricklin SV-1.Reported by Julia Wong. Produced by Kory Siegers and Liz Hoath / Originally aired on The Current.Storylines is part of the CBC Audio Doc Unit

Murray Sinclair was honoured today in a national ceremony in Winnipeg. We'll take you to today's memorial and those paying tribute.Also: U.S. President-elect Donald Trump is narrowing down who will join his inner circle, ruling out some of his most prominent critics as he prepares for his return to the White House.And: Opioid overdoses kill thousands of Canadians each year. That is leading some politicians and experts to push a new and controversial approach to addiction -- forcing people into treatment.Plus: The first suspected human case of bird flu in Canada, misinformation spreading in Spain, Dene men taking up sewing and more.

BUFFALO, NY- October 23, 2024 – A new #editorial was #published in Oncotarget's Volume 15 on October 11, 2024, entitled, “Gene regulatory network and signalling pathway rewiring: How blood cancer cells shift their shapes to evade drug treatment.” As highlighted in the paper, Acute Myeloid Leukemia (AML) is a complex and diverse disease caused by multiple mutations in genes that regulate transcription and growth. These mutations lead to extensive rewiring of the gene regulatory network (GRN), which alters the identity of hematopoietic stem and progenitor cells, ultimately blocking normal myeloid differentiation. A key feature of AML is the presence of mutations in growth factor receptor and signaling genes, such as FLT3, KIT, and RAS. Notably, FLT3 is one of the most commonly mutated genes in AML, with around 25% of cases showing an internal tandem duplication (ITD) that causes the receptor to remain constantly active. In their paper, researchers Constanze Bonifer and Peter N. Cockerill from the Institute of Cancer and Genomic Sciences at the University of Birmingham, UK, and the Murdoch Children's Research Institute, Royal Children's Hospital in Melbourne, Australia, discuss recent publications from their group addressing this issue through a multi-omics study. The authors investigated how gene regulatory networks (GRNs) in FLT3-ITD patients were rewired compared to normal cells and in response to FLT3 inhibitor treatment. Several key findings stood out, including: 1) Mapping of open chromatin regions revealed that patients initially responsive to FLT3 inhibition showed significant rewiring of their GRNs, forming new connections between transcription factors (TFs) and target genes, while non-responsive patients did not; 2) Chromatin immunoprecipitation (ChIP) experiments showed that drug treatment led to the loss of binding of RUNX1, the master regulator of hematopoiesis, and the MAP-Kinase (MAPK)-inducible TF AP-1; 3) Disruption of AP-1 binding via a dominant-negative version of the TF (dnFOS) also abolished RUNX1 binding at hundreds of sites, indicating that RUNX1 binding is AP-1 dependent; and 4) Inhibition of both AP-1 and RUNX1 led to a pronounced cell cycle block. “In summary, drugs that target individual signalling pathways in AML often fail to stop proliferation malignant growth, due to the wide variety, redundancy and cross talk between multiple pathways regulating and differentiation.” DOI - https://doi.org/10.18632/oncotarget.28662 Correspondence to - Constanze Bonifer - constanze.bonifer@mcri.edu.au Video short - https://www.youtube.com/watch?v=5c_uT6aE36A Sign up for free Altmetric alerts about this article: https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28662 Subscribe for free publication alerts from Oncotarget: https://www.oncotarget.com/subscribe/ Keywords - cancer, acute myeloid leukemia, gene regulatory networks, aberrant growth factor signaling, transcription, RUNX1/AP-1 axis About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh

Unpacking the arguments for and against Measure R in the Central Valley. Why Republican registration is ticking up among California voters. Finally, Sacramento artist Uli Smith's new exhibit "be/long/ing" at Sac State. Mandatory Drug Treatment Under Measure R

Eddie Mullins. Chief Executive Officer of Merchants Quay Ireland, discusses the increase in demand for their services.

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Drug treatment of hypertrophic cardiomyopathy Humour in medicine Statistics Made Easy: Regression analysis Host: Susanna Price Guests: Carlos Aguiar, Milind Desai, Rohin Francis Want to watch that episode? Go to: https://esc365.escardio.org/event/1156   Disclaimer: ESC TV Today and ESC 365, the cardiology knowledge hub are supported by Bristol Myers Squibb. The scientific content and opinions expressed in this programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.   Declarations of interests Stephan Achenbach, Rohin Francis, Antonio Greco, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report.  Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic. Milind Desai has declared to have potential conflicts of interest to report: consultant and research agreements with Bristol Myers Squibb, Tenaya, Edgewise, Cytokinetics and VIZ AI. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

This week on Everyday Injustice, we sit down with LaToya Mitchell, Navigator Project Manager, CA Bridge Program and talked about the innovative program that helps get people from ER into drug treatment and reduce annual drug overdoses. A few weeks ago, she was part of a rally at the California Capitol to push for a package of bills that would improve access to programs such as the Bridge Navigator Project. The navigator program allows ER patients to connect with treatment medication and staff immediately. Mitchell explained, “What most people don't know is that it is the easiest substance use disorder to treat because medication like buprenorphine, which is commonly known by the brand name Suboxone, acts fast to stop the withdrawals without euphoria and allows the patient to feel like themselves before the addiction.” Her job is to lower the barriers for patients to receive the treatment. She said that “there's a lot of stigma for people who use drugs and that creates barriers like obtaining a Suboxone prescription from big chain pharmacies, so it's essential that I know which pharmacies are Suboxone friendly and provide that list to the patients.” Mitchell noted, “We found that with the presence of the navigator, patients felt more comfortable coming in and saying, I'm here because I'm having opioid withdrawals, as opposed to them naming their symptoms and because they were afraid of admitting their substance use. Because of that, we're able to get them treated and in and out in a couple of hours. Instead of spending six hours in the emergency room getting unnecessary and costly tests, we found that it actually saved resources and a lot of money.” Listen as Latoya Mitchell discusses the importance of harm reduction and the use of treatment over incarceration.

This time on Code WACK! How do insurance companies put up barriers to addiction treatments? How does this affect treatment programs and their clients? And how would it be if we had Medicare for All? To find out, we spoke to Arlene Stanich-Prince, executive director of Ohlhoff Recovery Programs in San Francisco, one of the longest standing treatment programs in the area. This is the first of two episodes with Stanich-Prince. Check out the Show Notes and Transcript for more!  

In this compelling episode of The Mark and Pete Show, hosts Mark and Pete dive into the pressing issue of prison overcrowding and explore forward-thinking alternatives to traditional incarceration. Join them as they discuss innovative solutions that prioritize rehabilitation, restorative justice, and community-based sanctions over confinement. Featuring expert interviews and real-world case studies, this episode sheds light on how we can transform the criminal justice system to create safer, more compassionate communities. From electronic monitoring to restorative justice programs, discover the potential pathways to a more effective and humane approach to crime and punishment.Become a supporter of this podcast: https://www.spreaker.com/podcast/mark-and-pete--1245374/support.

In this compelling episode of The Mark and Pete Show, hosts Mark and Pete dive into the pressing issue of prison overcrowding and explore forward-thinking alternatives to traditional incarceration. Join them as they discuss innovative solutions that prioritize rehabilitation, restorative justice, and community-based sanctions over confinement. Featuring expert interviews and real-world case studies, this episode sheds light on how we can transform the criminal justice system to create safer, more compassionate communities. From electronic monitoring to restorative justice programs, discover the potential pathways to a more effective and humane approach to crime and punishment.Become a supporter of this podcast: https://www.spreaker.com/podcast/mark-and-pete--1245374/support.

This time on Code WACK! What are some of the most common misconceptions about people who are addicted to substances like opioids? What medicines are revolutionizing the way people are being treated today – and how accessible are they?  To find out, we spoke to Arlene Stanich-Prince, executive director of Ohlhoff Recovery Programs in San Francisco, one of the longest standing treatment programs in the area. This is the first of two episodes with Stanich-Prince. Check out the Show Notes and Transcript for more!  

In our ongoing coverage of issues plaguing the Children's Division of Missouri's Department of Social Services, we discuss why a tool aimed at removing children from a home where drug use is evident isn't being used to a great extent in the St. Louis area. STLPR politics correspondent talks about his reporting on the Temporary Alternative Placement Agreement — or TAPA.

Across Mexico, clandestine treatment centers for drug addiction – locally referred to as anexos – have been accused of unethical therapeutic practices and even patient abuse. But among Mexico's working poor, in the absence of government support, they provide hope and protection from the country's catastrophic drug war. Anthropologist Angela Garcia spent a decade studying anexos, getting to know the people who run them and families that have come to rely on them. She chronicles their stories and her own reflections in her new book, “The Way That Leads Among The Lost: Life, Death, and Hope In Mexico City's Anexos.” Guests: Angela Garcia, associate professor of anthropology, Stanford; author of the new book “The Way That Leads Among The Lost: Life, Death, and Hope In Mexico City's Anexos”

The City Cast team is here to round up the news of the week. Bianca Martin, Hayley Sperling and Molly Stentz recap the mysterious hold-up of state money for drug treatment and prevention programs. Plus, we discuss the creative proposal to build new affordable housing on East Wash in exchange for student housing on campus. And part of State Street's going pedestrian-only starting May 8th. That's why the flamingoes are everywhere.

Recovery doesn't happen in a vacuum any more than addiction does. Family, friends, and coworkers are all affected by the disease. Jim Savage discusses the importance of family education and support in recovery. Jim is the owner of “Rehab Works! Family Support Program” and Jim Savage Consulting. He is the author of Rehab Works! A Parent's Guide to Drug Treatment and a new ebook, Sobriety Doesn't Have To Suck: A Guide To Finding Happiness, Excitement, And Spiritual Fulfillment In Recovery. Jim has been helping individuals and families in recovery for over three decades. Jim's' contact information, video series, trainings, and other works can be accessed at Jim Savage, LCDC The views and opinions of the guests on this podcast are theirs and theirs alone and do not necessarily represent those of the host, Westwords Consulting or the Kenosha County Substance Abuse Coalition. We're always interested in hearing from individuals or organizations who are working in substance use disorder treatment or prevention, mental health care and other spaces that lift up communities. This includes people living those experiences. If you or someone you know has a story to share or an interesting approach to care, contact us today! Follow us on Facebook, LinkedIn, and YouTube. Subscribe to Our Email List to get new episodes in your inbox every week!

Welcome to our weekly live show, Overtime with Coach Blu and Athletic Director Marissa. Coach Blu is a licensed mental health therapist and certified substance use disorder counselor. Today's cohost is Addict II Athlete's own Athletic Director, Marisa Robinson. Marissa is a Certified Recreational Therapist. This is an open topic, so you, the listener, can participate by submitting your own questions through direct messaging or jumping on the Zoom link provided to be a guest and participant on the show. We discuss topics of addiction, recovery, mental illness, health and wellness, and much more. Today we are talking about drug discrimination.

Welcome to our weekly live show, Overtime with Coach Blu and Athletic Director Marissa. Coach Blu is a licensed mental health therapist and certified substance use disorder counselor. Today's cohost is Addict II Athlete's own Athletic Director, Marisa Robinson. Marissa is a Certified Recreational Therapist. This is an open topic, so you, the listener, can participate by submitting your own questions through direct messaging or jumping on the Zoom link provided to be a guest and participant on the show. We discuss topics of addiction, recovery, mental illness, health and wellness, and much more. Today we are talking about drug discrimination.

Gerald's arguing for safe supply, police officer Anton sees a role for "involuntary" drug treatment, Ben says Big Oil's not pulling its weight, and Kat says Alberta needs to get serious about health supports: it's The Flamethrower presented by the Dairy Queens of Northwest Edmonton and Sherwood Park! Fire up your Flamethrower: talk@ryanjespersen.com

Politicians and educators agree that the large number of Indiana students missing school is a serious problem - there's less consensus on what policies could help. Lawmakers want to get pregnant people who have been charged with drug crimes into treatment earlier. Adult websites would have to use stricter age verification to operate in Indiana under legislation headed to the governor's desk. Another piece of legislation headed to the governor aims to make Indiana's disaster relief program easier to access, while providing more money for those in need. Indiana Republicans are interfering in a lawsuit by the city of Gary against gun manufacturers and sellers. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. Today's episode of WFYI News Now was produced by Darian Benson, Abriana Herron, Drew Daudelin and Kendall Antron with support from Sarah Neal-Estes.

In this episode, Lexi and their bestie Sam discuss the basics of medication for depression and anxiety while sharing their personal medication journeys. The friends discuss how medication can help to strengthen neural pathways and how it can help dig you out of your hole. Resources for this episode:

Federal regulators are investigating Kaiser Permanente for how it treats women with postpartum depression. The health provider has twice revised its guidelines to make it easier for women to get a new drug that targets the condition. These developments are the result of a KQED investigation that first revealed Kaiser's restrictions on postpartum care. Guest: April Dembosky, KQED State surveyors have measured the snowpack near Lake Tahoe, and found only a small amount of snow compared to this time last year.  Reporter: Ezra David Romero, KQED

Michael Wallace has the top stories from the WCBS newsroom.

People who work within the program say it effectively reduces recidivism. But it can also be a challenging program to complete.

In this episode, Karol welcomes Jason Rantz to discuss the rise in crime and radical beliefs in America. Karol explores a robbery case in Brooklyn, where the victims blamed themselves, and the trend of supporting terrorists on TikTok. Rantz shares insights from his book, "What's Killing America: Inside the Radical Left Tragic Destruction of Our Cities," criticizing policies that enable drug users and the lack of pushback from local media. They also discuss the societal problem of narcissism and the importance of hard work. The Karol Markowicz Show is part of the Clay Travis & Buck Sexton Podcast Network - new episodes debut every Monday & Thursday.Follow Clay & Buck on YouTube: https://www.youtube.com/c/clayandbuckSee omnystudio.com/listener for privacy information.

In this episode, Karol welcomes Jason Rantz to discuss the rise in crime and radical beliefs in America. Karol explores a robbery case in Brooklyn, where the victims blamed themselves, and the trend of supporting terrorists on TikTok. Rantz shares insights from his book, "What's Killing America: Inside the Radical Left Tragic Destruction of Our Cities," criticizing policies that enable drug users and the lack of pushback from local media. They also discuss the societal problem of narcissism and the importance of hard work. The Karol Markowicz Show is part of the Clay Travis & Buck Sexton Podcast Network - new episodes debut every Monday & Thursday.See omnystudio.com/listener for privacy information.

Dr Mhairi Morris (Senior Lecturer in Biochemistry at Loughborough University) talks about the new NHS-approved breast cancer drug Anastrozole with Host Martin Foster. They also discuss how exercise and diet can help in preventing breast cancer alongside other topics.Timestamps 00:00 - 07:20 - Introductions to the guest, background and current projects07:21 - 11:29 - Breast cancer: how common is it?11:30 - 16:42 - Prevention: health, exercise and diet16:43 - 21:40 - Anastrozole: the new NHS-approved drug21:41 - 29:51 - How big is the effect of physical activity? 29:52 - 34:27 - Round up, thank you to guest and links for further learning

State health officials said a drug treatment center near Missoula failed to report serious incidents and did not follow other state regulations.

A scam to assign a patent for a publicly developed drug was exposed. All you need to know about the 2024 election, including constitutional amendments. Will Liz Cheney run? --- Send in a voice message: https://podcasters.spotify.com/pod/show/politicsdoneright/message Support this podcast: https://podcasters.spotify.com/pod/show/politicsdoneright/support

Dr. Lisa, Atika-J, and Chuck have an impromptu debate on mandated treatment, after discussing the NORS (National Overdose Response System) and how Ashes to Awesome has agreed to help get the word out.  Atika's email atika@j-initiative.org NORS https://www.nors.ca/ If you have a nonprofit or fundraiser that you would like to advertise for free and spread a five-minute dose of kindness to the world while doing it, you can on the latest Chuck LaFLange Production, ⁠Morning Cup of Kindness. ⁠ Details herehttps://WWW.A2APODCAST.COM/MCK Click ⁠https://www.a2apodcast.com⁠ for links to Chuck's new daily 5 min podcast, "Morning Cup of Kindness", all of our socials where we have posted some great short-form content to help inspire. If you are listening on the ⁠⁠Spotify platform⁠⁠, you are able to share your thoughts about an individual episode in the interactive element that Spotify offers. Doing this tickles the fancy of the algorithm and really helps us to spread the message. Also please visit our Facebook page ⁠⁠⁠here⁠⁠⁠, and like, share, or comment on any of the posts. Your feedback there is sincerely appreciated, and taken quite seriously. Lastly, most of our alumni guests from the podcast are members of our Facebook group. If you would like to get to know any of them, or have questions, or perhaps would like to invite them onto another show, this is a great place to interact. You can join that group ⁠⁠⁠here ⁠⁠⁠⁠⁠⁠⁠⁠.⁠⁠⁠⁠https://www.facebook.com/groups/79994..⁠.⁠⁠⁠⁠⁠⁠⁠⁠ Ours sponsors, that make spreading the message possible :Rosecrest Recovery Services Call 615-484-8792 or email info@rosecrestrecoveryservices.com Dent Kits - ⁠⁠⁠⁠⁠⁠⁠⁠http://⁠www.dentkits.com⁠⁠⁠⁠⁠⁠⁠⁠ ⁠Together ⁠⁠⁠⁠⁠⁠⁠⁠We Can Recovery Society ⁠http://www.⁠⁠twcrecoverylife.org⁠⁠⁠⁠⁠⁠⁠⁠⁠ Revolution Recovery -⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.revolution-recovery.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Yatra Trauma Therapy Center -⁠https://yatracentre.com/⁠ ⁠⁠Nate D Foundation =⁠⁠⁠⁠⁠⁠⁠⁠⁠https://nate-d.ca/⁠⁠⁠⁠⁠

On this week's episode we are joined by Kathy Icenhower, co-founder and CEO of Shields for Families. Three decades ago, against the backdrop of the crack epidemic, Icenhower started Shields out of a run-down trailer provided by the Los Angeles county government with Norma Ntume and Dr. Xylina Bean. It quickly became a pioneering organization in the fight to keep families together while parents pursued drug treatment. Icenhower talked with us about the evolution of Shields, when child removals are necessary in substance abuse cases, her concerns about the trends in treating addiction, and much more.Reading Room“Good News Radio Magazine” interview with Kathryn Icenhower and Norma Mtume. https://bit.ly/3PeAy8tSupporters, Not Reporters: Preventing Foster Care in Californiahttps://bit.ly/3sPI9THL.A. County Hopes to Expand Family-Finding Serviceshttps://bit.ly/3ZdElaT

August 1, 2023 - New York is investing $6 million in federal funds to operate mobile medication units to expand access to drug addiction services around the state. We discuss the initiative with Debbian Fletcher-Blake, president & CEO of VIP Community Services, which began operating a mobile unit this summer in New York City.

Holmberg's Morning Sickness - Brady Report - Friday June 30, 2023 Learn more about your ad choices. Visit megaphone.fm/adchoices